Now showing items 1-4 of 4
Skin autofluorescence and the association with renal and cardiovascular risk factors in chronic kidney disease stage 3.
BACKGROUND AND OBJECTIVES: Tissue advanced glycation end products (AGE) accumulation is a measure of cumulative metabolic stress. Assessment of tissue AGE by skin autofluorescence (SAF) correlates well with cardiovascular ...
The impact of antihypertensive drug therapy on endotoxemia in elderly patients with chronic kidney disease.
BACKGROUND AND OBJECTIVES: Endotoxin (ET) is recognized to cause adverse effects on cardiovascular (CV) structure. Circulatory translocation of gut bacterial ET is described in heart failure. Chronic kidney disease (CKD) ...
Effects of arteriovenous fistula formation on arterial stiffness and cardiovascular performance and function.
email@example.com BACKGROUND: Native arteriovenous fistula (AVF) is the vascular access of choice and its use cf. catheters is associated with sustained reduction in mortality. This may be due to factors beyond ...
Anthropomorphic measurements that include central fat distribution are more closely related with key risk factors than BMI in CKD stage 3.
BACKGROUND: Body Mass Index (BMI) as a marker of obesity is an established risk factor for chronic kidney disease (CKD) and cardiovascular disease (CVD). However, BMI can overestimate obesity. Anthropomorphic measurements ...